CSNK1G3

Across TCGA pan-cancer cohorts, CSNK1G3 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CSNK1G3 data layer compared with 28 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CSNK1G3 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated CSNK1G3 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, STAD, and CESC are the cancer types where CSNK1G3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.968	0.657	.024	14	view →
STAD	OS	Median	II,III,IV	0.501	0.660	.006	10	view →
CESC	OS	Median	All	0.127	0.588	.048	6	view →
LUAD	DFS	Median	IV	0.342	0.893	<.001	6	view →
SARC	OS	Median	All	0.523	0.863	.038	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CSNK1G3–UCEC (OS)

Open the UCEC breakdown →